Literature DB >> 26585953

Hoxa cluster genes determine the proliferative activity of adult mouse hematopoietic stem and progenitor cells.

Charles-Étienne Lebert-Ghali1, Marilaine Fournier1, Laura Kettyle2, Alexander Thompson2, Guy Sauvageau3, Janet J Bijl4.   

Abstract

Determination of defined roles for endogenous homeobox (Hox) genes in adult hematopoietic stem and progenitor cell (HSPC) activity has been hampered by a combination of embryonic defects and functional redundancy. Here we show that conditional homozygous deletion of the Hoxa cluster (Hoxa(-/-)) results in a marked reduction of adult HSPC activity, both in vitro and in vivo. Specifically, proliferation of Hoxa(-/-) HSPCs is reduced compared with wild-type (WT) cells in vitro and they are less competitive in vivo. Notably, the loss of Hoxa genes had little impact on HSPC differentiation. Comparative RNA sequencing analyses of Hoxa(-/-) and WT hematopoietic stem cells (CD150(+)/CD48(-)/Lineage(-)/c-kit(+)/Sca-1(+)) identified a large number of differentially expressed genes, three of which (Nr4a3, Col1a1, and Hnf4a) showed >10-fold reduced levels. Engineered overexpression of Hoxa9 in Hoxa(-/-) HSPCs resulted in partial phenotypic rescue in vivo with associated recovery in expression of a large proportion of deregulated genes. Together, these results provide definitive evidence linking Hoxa gene expression to proliferation of adult HSPCs.
© 2016 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26585953     DOI: 10.1182/blood-2015-02-626390

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

Review 1.  Role of Vitamin A/Retinoic Acid in Regulation of Embryonic and Adult Hematopoiesis.

Authors:  Ana Cañete; Elena Cano; Ramón Muñoz-Chápuli; Rita Carmona
Journal:  Nutrients       Date:  2017-02-20       Impact factor: 5.717

2.  Synergy of NUP98-HOXA10 Fusion Gene and NrasG12D Mutation Preserves the Stemness of Hematopoietic Stem Cells on Culture Condition.

Authors:  Yong Dong; Chengxiang Xia; Qitong Weng; Tongjie Wang; Fangxiao Hu; Kaitao Wang; Xiaofei Liu; Yang Geng; Lijuan Liu; Hongling Wu; Juan Du
Journal:  Cells       Date:  2019-08-22       Impact factor: 6.600

3.  SOX17 integrates HOXA and arterial programs in hemogenic endothelium to drive definitive lympho-myeloid hematopoiesis.

Authors:  Ho Sun Jung; Gene Uenishi; Mi Ae Park; Peng Liu; Kran Suknuntha; Matthew Raymond; Yoon Jung Choi; James A Thomson; Irene M Ong; Igor I Slukvin
Journal:  Cell Rep       Date:  2021-02-16       Impact factor: 9.423

4.  Medial HOXA genes demarcate haematopoietic stem cell fate during human development.

Authors:  Diana R Dou; Vincenzo Calvanese; Maria I Sierra; Andrew T Nguyen; Arazin Minasian; Pamela Saarikoski; Rajkumar Sasidharan; Christina M Ramirez; Jerome A Zack; Gay M Crooks; Zoran Galic; Hanna K A Mikkola
Journal:  Nat Cell Biol       Date:  2016-05-16       Impact factor: 28.824

5.  The histone chaperone NAP1L3 is required for haematopoietic stem cell maintenance and differentiation.

Authors:  Yaser Heshmati; Shabnam Kharazi; Gözde Türköz; David Chang; Esmat Kamali Dolatabadi; Johan Boström; Aleksandra Krstic; Theodora Boukoura; Emma Wagner; Nadir Kadri; Robert Månsson; Mikael Altun; Hong Qian; Julian Walfridsson
Journal:  Sci Rep       Date:  2018-07-25       Impact factor: 4.379

6.  Chromatin accessibility promotes hematopoietic and leukemia stem cell activity.

Authors:  Lucia Cabal-Hierro; Peter van Galen; Miguel A Prado; Kelly J Higby; Katsuhiro Togami; Cody T Mowery; Joao A Paulo; Yingtian Xie; Paloma Cejas; Takashi Furusawa; Michael Bustin; Henry W Long; David B Sykes; Steven P Gygi; Daniel Finley; Bradley E Bernstein; Andrew A Lane
Journal:  Nat Commun       Date:  2020-03-16       Impact factor: 14.919

7.  Pathways, Processes, and Candidate Drugs Associated with a Hoxa Cluster-Dependency Model of Leukemia.

Authors:  Laura M Kettyle; Charles-Étienne Lebert-Ghali; Ivan V Grishagin; Glenda J Dickson; Paul G O'Reilly; David A Simpson; Janet J Bijl; Ken I Mills; Guy Sauvageau; Alexander Thompson
Journal:  Cancers (Basel)       Date:  2019-12-17       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.